Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q1 2022 · 10-Q
Revenue$69.38M$69.38M+71.9% vs Q1 2021 Net Income-$16.69M-$16.69MN/M vs Q1 2021 EPS Diluted-$0.61-$0.61N/M vs Q1 2021 Gross Profit$59,378,000+72.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flow-$12,748,000N/M Free Cash Flowderived-$13,963,000N/M Margins · derivedGross margin85.6%+0.4 pt vs Q1 2021
Operating margin-23.1%+15.7 pt vs Q1 2021
Net margin-24.1%+16.1 pt vs Q1 2021
ended Mar 31, 2022 · filed May 3, 2022 · 33 d after period end